S
The Good Signal
Tuesday, October 6, 2026Daily Edition
Women’s and men’s organs just got separate aging clocks
Lead StoryHealth

Women’s and men’s organs just got separate aging clocks

Nature Medicine on 16 September 2026 published 38 sex-specific biological aging clocks across 15 organs from Columbia’s MULTI Consortium; brain MRI clocks predicted MCI→AD with HR 1.74 in men and 2.25 in women per 1-SD older brain — research tools, not a consumer longevity score.

The Good SignalRead Story
Science & Technology

One brain implant just drove speech and gestures together

On 14 September 2026 Nature Neuroscience reported that a single high-density ECoG implant decoded speech and upper-limb gestures in parallel in people with paralysis, driving a personalized full-body avatar. In real-time copy tasks, one participant reached about 70% speech and 66% gesture accuracy across 10 phrases and 10 gestures (chance ~9% each). Proof-of-concept multi-effector BCI, not a consumer product.

Science & Technology

Stanford mice now grow a human cortex in their heads

On 16 September 2026 Stanford Medicine reported in Nature that human cortical organoids transplanted into “apallial” mice — engineered to lack most cortex and hippocampus — expanded nearly fivefold and filled more than 90% of the vacant cortical volume within two to three months, wiring into mouse circuits including the spinal cord and producing rare von Economo–like neurons (~1 in 90,000 cortical cells). A research model for neurodevelopment and injury, not a human therapy.

Science & Space

NASA spotted a once-in-132-year Moon crater 728 feet wide

On 16 September 2026 NASA reported that Lunar Reconnaissance Orbiter images caught McGetchin, a fresh Moon crater 728 feet (222 m) wide and 141 feet deep, carved in spring 2024. Science Advances papers call it a once-in-132-year-class event — the largest contemporary impact crater yet found in the solar system — with a multi-kilometer nighttime cold spot.

Health

A blood test caught 84% of early pancreatic cancers

On 16 September 2026 Nature Medicine published PANXEON, a City of Hope–led blood assay combining a 10-microRNA exosome signature with CA19-9. In a prospective study of 1,852 people across four countries, the miRNA signature alone hit AUC 88.6% and 83.8% sensitivity for early-stage pancreatic ductal adenocarcinoma; with CA19-9, sensitivity reached 86.8% for stage I–II. It is a biomarker study, not an FDA-cleared screening test.

More Stories

Posts

Health

FDA clears a breast cancer pill for a resistance mutation

On 4 September 2026 the FDA granted accelerated approval to camizestrant (Etcamah, AstraZeneca) with a CDK4/6 inhibitor for adults with HR+/HER2− advanced breast cancer when an ESR1 mutation appears on an FDA-authorized test during AI + CDK4/6 therapy. In SERENA-6 (n=315), median PFS was 16 months vs 9.2 months (HR 0.44). OS is immature; confirmatory trials are required.